Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19875 | 422 | 30.4 | 82% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 708 | 12194 | CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CILNIDIPINE | Author keyword | 93 | 74% | 17% | 70 |
| 2 | BENIDIPINE | Author keyword | 59 | 62% | 14% | 61 |
| 3 | AZELNIDIPINE | Author keyword | 40 | 66% | 9% | 38 |
| 4 | CAS 91599 74 5 | Author keyword | 15 | 88% | 2% | 7 |
| 5 | BENIDIPINE HYDROCHLORIDE | Author keyword | 6 | 58% | 2% | 7 |
| 6 | L N TYPE CALCIUM CHANNEL BLOCKER | Author keyword | 6 | 100% | 1% | 4 |
| 7 | CAS 105979 17 7 | Author keyword | 3 | 100% | 1% | 3 |
| 8 | CONIEL R | Author keyword | 3 | 100% | 1% | 3 |
| 9 | SM 6586 | Author keyword | 3 | 100% | 1% | 3 |
| 10 | N TYPE CALCIUM CHANNEL | Author keyword | 3 | 18% | 4% | 16 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CILNIDIPINE | 93 | 74% | 17% | 70 | Search CILNIDIPINE | Search CILNIDIPINE |
| 2 | BENIDIPINE | 59 | 62% | 14% | 61 | Search BENIDIPINE | Search BENIDIPINE |
| 3 | AZELNIDIPINE | 40 | 66% | 9% | 38 | Search AZELNIDIPINE | Search AZELNIDIPINE |
| 4 | CAS 91599 74 5 | 15 | 88% | 2% | 7 | Search CAS+91599+74+5 | Search CAS+91599+74+5 |
| 5 | BENIDIPINE HYDROCHLORIDE | 6 | 58% | 2% | 7 | Search BENIDIPINE+HYDROCHLORIDE | Search BENIDIPINE+HYDROCHLORIDE |
| 6 | L N TYPE CALCIUM CHANNEL BLOCKER | 6 | 100% | 1% | 4 | Search L++N+TYPE+CALCIUM+CHANNEL+BLOCKER | Search L++N+TYPE+CALCIUM+CHANNEL+BLOCKER |
| 7 | CAS 105979 17 7 | 3 | 100% | 1% | 3 | Search CAS+105979+17+7 | Search CAS+105979+17+7 |
| 8 | CONIEL R | 3 | 100% | 1% | 3 | Search CONIEL+R | Search CONIEL+R |
| 9 | SM 6586 | 3 | 100% | 1% | 3 | Search SM+6586 | Search SM+6586 |
| 10 | N TYPE CALCIUM CHANNEL | 3 | 18% | 4% | 16 | Search N+TYPE+CALCIUM+CHANNEL | Search N+TYPE+CALCIUM+CHANNEL |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | FRC 8653 | 31 | 92% | 3% | 12 |
| 2 | L N TYPE | 24 | 91% | 2% | 10 |
| 3 | CILNIDIPINE | 20 | 57% | 6% | 24 |
| 4 | BLOCKER CILNIDIPINE | 8 | 100% | 1% | 5 |
| 5 | KW 3049 | 8 | 100% | 1% | 5 |
| 6 | CS 905 | 7 | 64% | 2% | 7 |
| 7 | SM 6586 | 6 | 100% | 1% | 4 |
| 8 | NIFEDIPINE RETARD | 5 | 54% | 2% | 7 |
| 9 | AZELNIDIPINE | 5 | 43% | 2% | 9 |
| 10 | BENIDIPINE | 4 | 31% | 3% | 11 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Cilnidipine: A New Generation Ca2+ Channel Blocker with Inhibitory Action on Sympathetic Neurotransmitter Release | 2009 | 23 | 114 | 44% |
| Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker | 2006 | 26 | 95 | 62% |
| Ca2+ channel subtypes and pharmacology in the kidney | 2007 | 96 | 140 | 11% |
| Cilnidipine: Preclinical profile and clinical evaluation | 1999 | 10 | 19 | 74% |
| Suppression of Aldosterone Synthesis and Secretion by Ca2+ Channel Antagonists | 2012 | 4 | 49 | 22% |
| Azelnidipine (CS-905), a novel dihydropyridine calcium channel blocker with gradual onset and prolonged duration of action | 1995 | 7 | 6 | 83% |
| Benidipine: A new Ca2+ channel blocker with a cardioprotective effect | 1999 | 21 | 44 | 41% |
| Clinical use of azelnidipine in the treatment of hypertension in Chinese patients | 2015 | 0 | 26 | 27% |
| The organ-protective effect of N-type Ca2+ channel blockade | 2015 | 0 | 102 | 17% |
| BENIDIPINE | 1989 | 2 | 10 | 40% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MED BIOCHEM CARDIOVASC BIOL | 2 | 30% | 1.4% | 6 |
| 2 | ANALYT PHARMACOKINET | 1 | 40% | 0.5% | 2 |
| 3 | CELL MOL MED GRP | 1 | 50% | 0.2% | 1 |
| 4 | CELL PHYSIOL MOL BIOL | 1 | 50% | 0.2% | 1 |
| 5 | ENDOCRINOL METABMINATO KU | 1 | 50% | 0.2% | 1 |
| 6 | INTERNAL MED 2 HYPERTENS VASC | 1 | 50% | 0.2% | 1 |
| 7 | MOL CARDIOVASC METAB | 1 | 50% | 0.2% | 1 |
| 8 | MOL CELL BIOL DNA MEDMINATO KU | 1 | 50% | 0.2% | 1 |
| 9 | NEPHROL HYPERTENS ENDOCRINOLITABASHI KU | 1 | 13% | 0.9% | 4 |
| 10 | HYPERTENS CARDIORENAL DIS | 1 | 12% | 0.9% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000223287 | AMLODIPINE//DILTIAZEM CR//BESYLATE |
| 2 | 0.0000161174 | ANTIOXIDANT PHARMACOL//NITROSONIFEDIPINE//MYOCYTE MIGRATION |
| 3 | 0.0000136902 | MIBEFRADIL//T TYPE CALCIUM CHANNEL//T TYPE CALCIUM CHANNELS |
| 4 | 0.0000126233 | MEBUDIPINE//BARNIDIPINE HYDROCHLORIDE//BARNIDIPINE |
| 5 | 0.0000121629 | LERCANIDIPINE//LACIDIPINE//LERCANIDIPINE HYDROCHLORIDE |
| 6 | 0.0000101822 | PRANIDIPINE//OPC 13340//CAS 99522 79 9 |
| 7 | 0.0000079836 | FELODIPINE//NORMOTENSIVE VOLUNTEERS//ARANIDIPINE |
| 8 | 0.0000070667 | DUAL BLOCKADE//RENOPROTECTION//NONDIABETIC RENAL DISEASE |
| 9 | 0.0000069190 | AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY |
| 10 | 0.0000057786 | SR 33557//SR33805//H 3PN200 110 |